Image

The IMPACT PAD Study

The IMPACT PAD Study

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

Defining the role of intraprocedural physiology measurements in peripheral endovascular treatment

Description

Endovascular treatment for peripheral arterial disease is commonly performed for claudication or critical limb threatening ischaemia (ischaemic rest pain, foot ulcer or gangrene). Disease is generally identified using Ankle Brachial Pressure Index or Toe Brachial Pressure Index and then lesions delineated using Doppler ultrasound or CT angiography. Clinical severity is staged using absolute walking distance (metres) in claudicants or the Society for Vascular Surgery wIfI (wound, ischaemia, foot infection) score in critical limb threatening ischaemia patients.

Intra-procedural lesion assessment and quality control is currently performed anatomically using angiography alone, with a few centres using pullback pressures across a lesion to give supplementary trans-lesional gradients or intravascular ultrasound (IVUS) to give pre and post intervention diameter and vessel area measurements. No direct or quantitative assessment of flow, or pressure normalisation across lesions is currently performed during interventions to improve blood flow to the leg.

Eligibility

Inclusion Criteria:

  • 18 years of age
  • Peripheral arterial stenosis scheduled for endovascular treatment

Exclusion Criteria:

  • < 18 year of age
  • Unable to give informed consent
  • Estimated GFR ≤30 mL/min
  • Dialysis dependent
  • Unable to receive antiplatelets or periprocedural anticoagulation
  • Pregnancy or breastfeeding
  • Contraindication to adenosine (severe asthma or COPD)
  • WIfI ulcer score <2 (no exposed bone)
  • WIfI infection score <2 (skin and subcutaneous tissues only)
  • WIfI gangrene score <3 (limited to digits)
  • COVID-19 positive
  • NYHA IV heart failure
  • Contra-indication to adenosine including arrhythmia, asthma or allergy

Study details
    Peripheral Arterial Disease

NCT05035771

Mid and South Essex NHS Foundation Trust

28 January 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.